Prescription drug growth rates declined from 2000 to 2013, in part due to patent expiries and decreases in generic prices. However, this downward trend is reversing; spending on prescriptions is estimated to have spiked upwards in 2014 and 2015 with grow rates of 11.4% and 9.6% respectively.